Future directions in cardiac resynchronization therapy.

Area of Science:

• Cardiology
• Medical Devices
• Heart Failure Management

Background:

• Cardiac resynchronization therapy (CRT) is established for moderate-to-severe heart failure (NYHA class III-IV) with reduced ejection fraction and wide QRS, indicating ventricular dyssynchrony.
• Current research is evaluating CRT's efficacy in specific patient subgroups, including those with atrial fibrillation, mild heart failure, or a need for antibradycardia pacing.

Purpose of the Study:

• To assess the expanding role and refine patient selection criteria for CRT.
• To investigate if adding mechanical dyssynchrony criteria improves CRT response rates (PROSPECT trial).
• To determine if CRT benefits patients with narrow QRS but mechanical dyssynchrony (RethinQ study).

Main Methods:

• Review of existing clinical trial data and ongoing research.
• Analysis of patient subgroups based on QRS width, ejection fraction, and presence of mechanical dyssynchrony.
• Evaluation of CRT outcomes in patients with atrial fibrillation, mild heart failure, and heart failure with preserved ejection fraction.

Main Results:

• CRT is effective in selected heart failure patients with wide QRS and ventricular dyssynchrony.
• The benefit of CRT in patients with atrial fibrillation, mild heart failure, or narrow QRS is under investigation.
• The role of mechanical dyssynchrony in predicting CRT response is being actively studied.

Conclusions:

• CRT offers significant benefits for specific heart failure populations.
• Further research is needed to optimize CRT patient selection and expand its application.
• Identifying mechanical dyssynchrony may enhance CRT's effectiveness in broader patient groups.